Reducing bloodstream infections from ICU catheters
Part of Blood & lymphatic, Infections clinical trials.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been in the intensive care unit (ICU) for at least 48 hours
- You have a central line (a large IV placed in a vein in your neck, chest, or groin) for more than 24 hours
- You are not pregnant
- You have never had a bloodstream infection from a central line before
- Your central line was placed in this hospital (not brought in from another hospital)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
This study compares two types of central lines used in sick newborns: one placed in the belly button (UVC) and one placed in an arm or leg vein (PICC). It looks at which type is safer, lasts longer, and causes fewer bloodstream infections.
This study tests a special fluid used to flush the catheter (called a 'lock') to see if it can prevent infections in newborns. If your baby has a central line, this could help reduce the risk of serious infections.
This study aims to reduce infections that can happen when you have a central line, which is a special tube placed in a large vein to give medicines or fluids. It will test ways to improve care for patients with these lines to prevent infections.
This study looks at ways to better treat central line infections that are hard to cure because of bacteria that stick to the tube. It may help find a treatment that works better for patients in intensive care.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
Hear when a new CLABSI - Central Line Associated Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.